Evgen Pharma (TCF) Stock Statistics & Valuation Metrics

Evgen Pharma has a market cap or net worth of £4.62M. The enterprise value is 3.60M .

Evgen Pharma has 2,148,963,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evgen Pharma’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -35.59%.

The current PE Ratio of Evgen Pharma is ―. Evgen Pharma’s PEG ratio is 0.00913.

In the last 12 months, Evgen Pharma had revenue of 0.00 and earned -1.94M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -1.68M and capital expenditures 0.00, giving a free cash flow of -1.68M billion.

Evgen Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Evgen Pharma upcoming earnings date is Dec 9, 2026, TBA (Confirmed).

Evgen Pharma as a current ratio of 3.11, with Debt / Equity ratio of 0.00%

In the past 12 months, Evgen Pharma has paid 144.00K in taxes.

Evgen Pharma EV to EBITDA ratio is 0.44, with an EV/FCF ratio of 0.38.

Evgen Pharma has £3.50M in cash and marketable securities with £0.00 in debt, giving a net cash position of £3.50M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Evgen Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―